Diabetic Nephropathy: New Directions in Management

References

• U. S. Renal Data System. The National Institutes of Health, National Institute of Diabetes and Digestive Diseases, Bethesda, MD Aug, 1989, USRDS 1989 Annual Data Report
   Google Scholar
• Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of the kidney. Am. J. Pathol 1936; 12: 83–97
   PubMedGoogle Scholar
• Sehimitz A, Vaeth M. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 1988; 5: 126–134
   Google Scholar
• Krolewski A S, Warram J H, Christlieb A R. Onset, course, complications, and prognosis of diabetes mellitus. Joslin's Diabetes Mellitused 12, A Marble, L P Krall, R F Bradley, A R Christlieb, J S Soeldner. Lea & Febiger, Philadelphia 1985; 251–277
   Google Scholar
• Krolewski A S, Warram J H, Christlieb A R, Busick E J, Kahn C R. The changing natural history of nephropathy in type I diabetes. Am J Med 1985; 78: 785–794
   PubMed Web of Science ®Google Scholar
• Krolewski A S, Warram J H, Rand L I, Kahn C R. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 1987; 317: 1390–1398
   PubMed Web of Science ®Google Scholar
• CDC. End-stage renal disease associated with diabetes—United States, 1888. MMWR 1989; 38: 546–548
   Google Scholar
• Health Care Financing Administration, Bureau of Data Management and Strategy, Data from the program management and medical information systems, 1979–1984, and census population estimates. Series P-25, no. 965
   Google Scholar
• Eggers P W. Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 1988; 318: 223–229
   PubMed Web of Science ®Google Scholar
• Smith D G, Harlan L C, Hawthorne V M. The charges for ESRD treatment of diabetics. J Clin Epidemiol 1989; 42: 111–118
   Google Scholar
• Markell M S, Friedman E A. Care of the diabetic patient with endstage renal disease. Sem Nephrol 1990; 10: 274–286
   Google Scholar
• Zander E, Schultz B, Gums G, et al. Causes of death in insulindependent diabetic patients treated with hemodialysis. J. Diabetic Comp 1989; 3: 163–166
   Google Scholar
• Najarian J S, Kaufman D B, Fryd D S. Long-term survival following kidney transplantation in 100 type I diabetic patients. Transplantation 1989; 47: 106–113
   PubMed Web of Science ®Google Scholar
• Strumpf C, Katz F, Wing A J, et al. Cardiovascular risk factors and cardiovascular death in hemodialyzed diabetic patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985; 21: 202–208
   Google Scholar
• Rosansky S J, Eggers P W. Trends in the US end-stage renal disease population: 1973–1983. Am J Kidney Dis 1987; 9: 91–97
   Google Scholar
• Eggers P W, Connerton R, McMullan M. The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival. Health Care Financing Rev 1984; 5: 69–88
   Google Scholar
• Friedman E A. Diabetic nephropathy. Textbook of Nephrology, S G Massry, R J Glassock. Williams & Wilkins, Baltimore 1989; 761–772
   Google Scholar
• Tuttle K R, Stein J H, Defronzo R A. The natural history of diabetic nephropathy. Sem Nephrol 1990; 10: 184–19
   Google Scholar
• Mogensen C E. Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function tests. The Kidney and Hypertension in Diabetes Mellitus, C E Mogensen. Martinus Nijhoff Publishing, Boston 1988; 7–16
   Google Scholar
• Krolewski A S, Warram J H, Christlieb A R. Onset, course, complications, and prognosis of diabetes mellitus. Joslin's Diabetes Mellitused 12, A Marble, L P Krall, R F Bradley, A R Christlieb, J S Soeldner. Lea & Febiger, Philadelphia 1985; 251–277
   Google Scholar
• Watkins P J, Grenfell A, Edmonds M. Diabetic complications of non-insulin dependent diabetes. Diabetic Med 1987; 4: 293–296
   Google Scholar
• Amoah E, Glickman J L, Malchoff C D, Sturgill B C, Kaiser D L, Bolton W K. Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction. Am. J. Nephrol 1988; 8: 204–211
   PubMed Web of Science ®Google Scholar
• Gail M, Skott P, Jorgensen H E, Jorgensen F, Larsen S. Prevalence and causes of albuminuria in non-insulin-dependent diabetic (NIDDM) patients. J Diab Comp 1989; 3: 172–178
   Google Scholar
• Schmitz A, Gundersen H JG, Osterby R. Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Lack of glomerular hypertrophy. Diabetes 1988; 37: 38–43
   Google Scholar
• Heptinstall R H. Diabetes mellitus and gout. Pathology of the Kidney, R M Heptinstall. Little, Brown, Boston 1983; 1397–1438
   Google Scholar
• Mauer S M, Steffes M W, Brown D M. The kidney in diabetes. Am J Med 1981; 70: 603–612
   PubMed Web of Science ®Google Scholar
• Fabre J, Balant L P, Dayer P G, Fox H M, Vernet A T. The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients. Kidney Int 1982; 21: 730–738
   PubMed Web of Science ®Google Scholar
• Hostetter T H, Daniels B S. National history of renal structural abnormalities in diabetes mellitus. The Kidney in Diabetes Mellitus, B M Brenner, J H Stein. Churchill Livingstone, New York 1989; 51–65
   Google Scholar
• Mauer S M, Steffes M W, Ellis E N, Sutherland D E, Brown D M, Goetz F C. Struetural-functional relationships in diabetic nephropathy. J Clin Invest 1984; 74: 1143–1155
   PubMed Web of Science ®Google Scholar
• Kimmelstiel P, Wilson C. Intereapillary lesions in the glomeruli of the kidney. Am J Pathol 1936; 12: 83–97
   PubMedGoogle Scholar
• Zander E, Schultz B, Gums G, Lorenz G, Warzok R. Causes of death in insulin-dependent diabetic patients treated with hemodialysis. J Diabetic Comp 1989; 3: 163–166
   Google Scholar
• Avram M M, Fein P A, Antignani A, Mittman N, Goldwasser P. Cholesterol and lipid disturbances in renal disease: The natural history of urcmic dyslipidemia and the impact of hemodialysis and chronic ambulatory peritoneal dialysis. Am J Med 1989; 87, 5–55N-5–60N
   Google Scholar
• , Report of the National CAPD Registry of the National Institutes of Health: 1/1/81–8/31/85. National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases. US Department of Health and Human Services, Washington DC. Jan 1986
   Google Scholar
• Diaz-Buxo J A, Burgess W P, Greenman M. Visual function in diabetic patients undergoing hemodialysis: Comparison of peritoneal and hemodialysis. Int J Artif Organs 1984; 7: 257–262
   Google Scholar
• Najarian J S, Canafax D M, Sutherland D E. Renal transplantation in diabetic patients is confirmed therapy while pancreas transplantation should be performed only in an investigational setting. J Diabetic Comp 1988; 2: 158–161
   Google Scholar
• Larsson O, Attman P O, Blohme I. Morbidity and mortality in diabetic and non-diabetic recipients of living related donor kidneys. Nephrol Dial Trans 1987; 2: 109–116
   Google Scholar
• Khauli R B, Novick A C, Braun W E. Improved results of renal transplantation in the diabetic patient. J Urol 1983; 130: 867
   Google Scholar
• Markell M S, Friedman E A. Hyperlipidemia after organ transplantation. Am J. Med 1989; 87: 5–61N–5–67N
   Google Scholar
• Markell M S, Friedman E A. Care of the diabetic patient with end-stage renal disease. Sem Nephrol 1990; 10: 274–286
   Google Scholar
• Hostetter T H, Olson J L, Rennke H G, Venkatachalam M A, Brenner E M. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Phys 1981; 241: F85–F93
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Fogo A, Ichikawa I. Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 1989; 35: 654–660
   PubMedGoogle Scholar
• Harris D CH, Chan L, Schrier R W. Remnant kidney hypermetabolism and progression of chronic renal failure. Am J Physiol 1988; 254: F267–F276
   PubMed Web of Science ®Google Scholar
• Purkerson M L, Hoffsten P E, Klahr S. Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 1976; 9: 407
   PubMed Web of Science ®Google Scholar
• Peric-Golia L, Peric-Golia M. Aortic and renal lesions in hyper-cholesterolemic adult, male virgin Sprague-Dawley rats. Athereosclerosis 1983; 46: 57–65
   Web of Science ®Google Scholar
• Moise T S, Smith A H. The effect of high protein diet on the kidneys: An experimental study. Arch Pathol 1927; 4: 530–542
   Google Scholar
• Chanutin A, Ludewig S. Experimental renal insufficiency produced by partial nephrectomy; diets containing whole dried meat. Arch Int Med 1936; 58: 60–80
   Google Scholar
• Smadel J E, Farr L E. The effect of diet on the pathologic changes in rats with nephrotoxic serum nephritis. Am J Pathol 1939; 15: 199–216
   PubMedGoogle Scholar
• Levin D M, Cade R. Metabolic effects of dietary protein in chronic renal failure. Ann Intern Med 1965; 4: 642–653
   Google Scholar
• Giordano C. Early diet to slow the course of chronic renal failure. Proc 8th Int Cong Nephrol, Athens, W Zurukzoglu, M Papadimitrious, M Pyrpasopoulos, M Sion, C Zamboulis. 1981; 71–87
   Google Scholar
• Maschio G, Oldrizzo L O, Tessitore N, D'Angelo A, Valvo E, Loup A, Loschiavo C, Fabris A, Gammaro L, Rugiu C, Panzetta G. Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney Int 1982; 22: 371–376
   PubMed Web of Science ®Google Scholar
• Rosman J B, Meijer S, Sluiter W J, Wee P MT, Piers-Becht T PM, Donker A JM. Prospective randomized trial of early dietary protein restriction in chronic renal failure. Lancet 1984; 2: 1291–1295
   PubMed Web of Science ®Google Scholar
• Oldrizzi L, Rugiu C, Valvo E, Lupo A, Loschiavo C, Gammaro L, Tessitore N, Fabris A, Panzetta G, Maschio G. Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet. Kidney Int 1985; 27: 553–557
   Google Scholar
• Gentile M G, Manna G M, Ferrario L, D'Amico G. Preliminary experience on dietary management of chronic renal failure. Contr Nephrol (Karger, Basel) 1986; 53: 102–108
   Google Scholar
• Evanoff G V, Thompson C S, Brown J, Weinman E J. The effect of dietary protein restriction on the progression of diabetic nephropathy. Arch Intern Med 1987; 147: 492–495
   Google Scholar
• Evanoff G, Thompson C, Brown J, Weinman E. Prolonged dietary protein restriction in diabetic nephropathy. Arch Intern Med 1989; 149: 1129–1133
   Google Scholar
• Barsotti G, Ciardella F, Morelli E, Cupisti A, Mantovanelli A, Giovannetti S. Nutritional treatment of renal failure in type 1 diabetic nephropathy. Clin Nephrol 1988; 29(6)280–287
   Google Scholar
• Walker J D, Dodds R A, Murrells R J, Bending J J, Mattock M B, Keen H, Viberti G C. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989; 8677: 1411–1414
   Google Scholar
• Tapp D C, Kobayashi S, Fernandes G, Venkatachalam M A. Protein restriction or calorie restriction? A critical assessment of the influence of selective calorie restriction on the progression of experimental renal disease. Sem Nephrol 1989; 9: 343–353
   PubMedGoogle Scholar
• Lumlertgul D, Burke T J, Gillum D M, Alfrey A C, Harris D C, Hammond W S, Schrier R W. Phosphate depletion arrests progression of chronic renal failure independent of protein intake. Kidney Int 1986; 29: 658–666
   PubMedGoogle Scholar
• Moorhead J F, Ei Nahas M, Chan M K, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 1982; 2: 1309–1311
   PubMed Web of Science ®Google Scholar
• Pell S, D'Alonzo C A. Some aspects of hypertension in diabetes mellitus. J Am Med Assoc 1967; 202: 104–110
   PubMed Web of Science ®Google Scholar
• Parving H, Hornmel E, Mathiesen E, Skott P, Edsberg M, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retionopathy and neuropathy in patients with insulin-dependent diabetes. Br Med J 1988; 296: 156–160
   PubMed Web of Science ®Google Scholar
• Anderson S, Brenner B M. Therapeutic benefit of converting enzyme inhibitors in progressive renal disease. Am J Hyper 1988; I: 380–383, Suppl
   Google Scholar
• Mogensen C E. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 1976; 36: 383–388
   PubMed Web of Science ®Google Scholar
• Mogensen C E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 1982; 285: 685–688
   PubMed Web of Science ®Google Scholar
• Parving H H, Smith U M, Andersen A R, Sveendsen P AA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983; 1: 1175–1179
   PubMed Web of Science ®Google Scholar
• Aubia J, Lojman L, Chine M, Lloveras J, Masramon K, Llorach I, Cuevas X, Puig J M. Hypertension and nephrotoxicity in the rate of decline in kidney function in diabetic nephropathy. Clin Nephrol 1987; 27: 15–20
   PubMedGoogle Scholar
• Anderson S, Rennke H G, Brenner B M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993–2000
   PubMed Web of Science ®Google Scholar
• Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sesaki Y. Effect of captopril on heavy proteinuria in azotemic diabetis. N Engl J Med 1985; 313: 1617–1620
   PubMed Web of Science ®Google Scholar
• Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects on angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986; 293: 471–474
   PubMed Web of Science ®Google Scholar
• Parving H H, Hommel E, Smidt U M. Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy. Br. Med J 1988; 297: 1086–1091
   PubMed Web of Science ®Google Scholar
• Valvo E, Bedogna V, Cassagrande P, Antiga L, Zomboini M, Boumartini F, Oldrizzi L, Rugiu C, Maschio G. Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations. Am J Med 1988; 85: 344–348
   PubMed Web of Science ®Google Scholar
• Parving H H, Hommel E, Nielsen M D, Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. Br Med J 1989; 299: 533–536
   PubMed Web of Science ®Google Scholar
• Purkerson M L, Joist J H, Yates J, Valdes A, Morrison A, Klahr S. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 1985; 82: 193–197
   PubMed Web of Science ®Google Scholar
• Donadio J V, Ilstrup D M, Holley K E, Romero J C. Platelet-inhibitor treatment of diabetic nephropathy A 10-year prospective study. Mayo Clin Proc 1988; 63: 3–15
   Google Scholar
• Hopper A H, Tindall H, Davies J A. Administration of aspirindipyridamole reduces proteinuria in diabetic nephropathy. Nephrol Dial Trans 1989; 4: 140–143
   PubMedGoogle Scholar
• Dvornik D, Simard-Duquesne N, Krami M. Polyol accumulation in galactosemic and diabetic rats: Control by an aldose reductase inhibitor. Science 1973; 192: 1146–1147
   Google Scholar
• Raskin P, Rosenstock J. Aldose reductase inhibitors and diabetic complications. Am J Med 1987; 83: 298–306
   PubMed Web of Science ®Google Scholar
• Beyer-Mears A, Ku L, Cohen M P. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Diabetes 1984; 33: 604–607
   PubMedGoogle Scholar
• Beyer-Mears A. The polyol pathway, sorbinil, and renal dysfunetion. Metabolism 1986; 35(Suppl 1)46–54
   Google Scholar
• Goldfarb S, Kern E, Simmons D. Differential effects of supplementary dietary inositol on glomerular hyperfiltration due to early diabetes and high protein diet. Clin Res 1987; 35: 623A
   Google Scholar
• Schmid-Schonbein H, Volger E. Red cell aggregation and red cell deformabilty in diabetes. Diabetes 1976; 25(Suppl. 2)897–902
   PubMedGoogle Scholar
• Caimi G. Blood viscosity and erythrocyte filterability: Their evaluation in diabetes mellitus. Horm Metab Res 1983; 15: 467–470
   Google Scholar
• Ferrari E, Floravanti M, Patti A L, Viola C, Solerte S B. Effects of long-term treatment (4 years) with pentoxifylline on haemorrheological changes and vascular complications in diabetic patients. Pharmatherapeutica 1987; 5: 26–39
   PubMedGoogle Scholar
• Schaap G H, Bilo H JG, Popp-Sniders C, Oe P L, Mulder C, Donker A JM. Effects of protein intake variation and omega-3 polyunsaturated fatty acids on renal function in chronic renal disease. Life Sci 1987; 41: 2759–2765
   PubMed Web of Science ®Google Scholar
• Barrientos A, Arteaga J, Rodicio J L, Ude F A, Alcazar J M, Ruilope L M. Role of the control of phosphate in the progression of chronic renal failure. Min Electr Metab 1982; 7: 27–133
   Google Scholar
• Eliahou H E, Cohen D, Hellberg B, Ben-David A, Herzog D, Shechter P, Kapuler S, Kogan N. Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man. Am J Nephrol 1988; 8: 295–290
   Google Scholar
• Viberti G C, Hill R D, Jarrett R D, et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430–1432
   PubMed Web of Science ®Google Scholar
• Mogensen C E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356–360
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen B, Mathiesen E R, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986; 1: 1300–1304
   Google Scholar
• Reichard P, Rosenquist U. Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retionopathy. J. Int Med 1989; 226: 81–87
   PubMedGoogle Scholar
• DCCT Research Group. Diabetes control and complications trial (DCCT): Results of feasibility study. Diabetes Care 1987; 10: 1–19
   PubMed Web of Science ®Google Scholar
• Marre M, Leblanc H, Suarez L, Guyenne T T, Menard J, Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 1987; 294: 1448–1452
   PubMed Web of Science ®Google Scholar
• Marre M, Chatellier G, Leblane H, Guyene T T, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988; 297: 1092–1095
   PubMed Web of Science ®Google Scholar
• Christensen C K, Mogensen C E. Antihypertensive treatment: Longterm reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function. J Diabetic Comp 1987; 1: 45–52
   Google Scholar
• Baba T, Murabayashi S, Takebe K. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type II (non-insulin-dependent) diabetic patients with microalbuminuria: A randomised controlled trial. Diabetologia 1989; 32: 40–44
   PubMed Web of Science ®Google Scholar
• Cohen D, Dodds R, Viberti G C. Effect of protein restriction in insulin dependent diabetics at risk of nephropathy. Br Med J 1987; 294: 795–798
   PubMedGoogle Scholar
• FitzSimmons S C, Agodoa L, Striker L, Conti F, Striker G. Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis and prevention. Am J Kidney Dis 1989; 13: 7–10
   Google Scholar